Infex Zatoki (Pseudoephedrine Hydrochloride, Ibuprofen)

Pseudoephedrine acts as an α‑adrenergic agonist, causing blood vessels in the nasal lining to constrict. This vasoconstriction reduces swelling and mucus formation, thereby improving airflow and easing congestion.

The appropriate dose is determined by the prescribing healthcare professional based on the patient’s age, condition, and overall health. Patients should follow the prescriber’s instructions and not exceed the recommended amount.

Safety data for Infex Zatoki in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their physician before using this medication.

To place an order, submit an enquiry on the Infex Zatoki product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Infex Zatoki combines the decongestant effect of pseudoephedrine with the analgesic‑antipyretic action of ibuprofen, offering simultaneous relief of congestion and pain. Using either component alone would address only one of those symptom groups, whereas the combination can simplify therapy and reduce the need for multiple tablets.

Store Infex Zatoki at ambient temperature, preferably below 25 °C, in the original container. Protect the tablets from moisture and direct sunlight to maintain potency throughout the shelf life.

Infex Zatoki is taken orally with a full glass of water. It should be swallowed whole and not chewed or crushed, unless otherwise directed by a healthcare professional.

Serious risks include severe allergic reactions such as anaphylaxis, significant elevation of blood pressure or heart rate, and gastrointestinal bleeding or ulcer formation, especially in patients with pre‑existing ulcer disease or who take other NSAIDs.

Infex Zatoki should be avoided in individuals with known hypersensitivity to pseudoephedrine, ibuprofen, or any excipients, in patients with uncontrolled hypertension, severe coronary artery disease, active gastric ulcer, or in children under the age recommended by the prescriber.